Hormonal Contraception for Women at Risk of HIV Infection

Samantha R. Green, MD,
Caitlyn M. Rerucha, MD, MSEd, FAAFP, CAQSM,
Carl R. Darnall Army Medical Center, Fort Hood, Texas

American Family Physician. 2026;113(6):535.

Author disclosure: No relevant financial relationships.

This clinical content conforms to AAFP criteria for CME.

Author disclosure: No relevant financial relationships.

  1. 1.Rohwer C, McCaul M, Hofmeyr GJ, et al. Hormonal contraception for women at risk of HIV infection. Cochrane Database Syst Rev. 2025(6):CD015701.
  2. 2.Daniels K, Abma JC. Current contraceptive status among females ages 15–49: United States, 2022–2023. NCHS Data Brief. 2025(539):10.15620/cdc/174618.
  3. 3.World Health Organization. Medical Eligibility Criteria for Contraceptive Use. 6th ed. November 3, 2025. Accessed November 8, 2025. https://www.who.int/publications/i/item/9789240115583
  4. 4.Nguyen AT, Curtis KM, Tepper NK, et al. U.S. Medical Eligibility Criteria for Contraceptive Use, 2024. MMWR Recomm Rep. 2024;73(4):1-126.

These are summaries of reviews from the Cochrane Library.

This series is coordinated by Corey D. Fogleman, MD, assistant medical editor.

A collection of Cochrane for Clinicians published in AFP is available at https://www.aafp.org/afp/cochrane.

Copyright © 2026 by the American Academy of Family Physicians.

This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP. See permissions for copyright questions and/or permission requests.